Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: The MD Anderson experience

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 332-339

  Jiang, Zhi Qin ^a,b   Yang, Kunyu ^c   Komaki, Ritsuko ^a   Wei, Xiong ^a   Tucker, Susan L ^a   Zhuang, Yan ^a   Martel, Mary K ^a   Vedam, Sastray ^a   Balter, Peter ^a   Zhu, Guangying ^d   Gomez, Daniel ^a   Lu, Charles ^a   Mohan, Radhe ^a   Cox, James D ^a   Liao, Zhongxing ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Early and late toxicity; IMRT; Non small cell lung cancer; Radiation induced toxicity

Indexed keywords

ADVERSE EVENTS; ANDERSONS; BODY WEIGHT; CLINICAL OUTCOME; COMMON TERMINOLOGY CRITERIA; DEFINITIVE RADIOTHERAPY; ESOPHAGITIS; FUNCTION OF TIME; IMRT; INTENSITY-MODULATED RADIATION THERAPY; INTENSITY-MODULATED RADIOTHERAPY; KAPLAN-MEIER METHOD; LONG-TERM FOLLOW-UP; LOW RATES; MEDIAN RADIATION; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; PERFORMANCE STATUS; PULMONARY FIBROSIS; RADIATION-INDUCED TOXICITY;

CHEMOTHERAPY; DERMATITIS; DOSIMETRY; DRUG PRODUCTS; PHYSICAL THERAPY; RADIOTHERAPY;

TOXICITY;

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; ESOPHAGITIS; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; INTENSITY MODULATED RADIATION THERAPY; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INJURY; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WEIGHT CHANGE;

ADULT; AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; CARCINOMA, NON-SMALL-CELL LUNG; ESOPHAGEAL STENOSIS; ESOPHAGITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PULMONARY FIBROSIS; RADIATION INJURIES; RADIATION PNEUMONITIS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TEXAS;

EID: 84859832006     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.1963     Document Type: Article

References (16)

1. H.H. Liu, X. Wang, and L. Dong Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 2004 1268 1279
2. I.S. Grills, D. Yan, and A.A. Martinez Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation Int J Radiat Oncol Biol Phys 57 2003 875 890
3. M. Schwarz, M. Alber, and J.V. Lebesque Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer Int J Radiat Oncol Biol Phys 62 2005 561 570
4. S.S. Yom, Z. Liao, and H.H. Liu Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 68 2007 94 102
5. Z.X. Liao, R.R. Komaki, and H.D. Thames Jr. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy Int J Radiat Oncol Biol Phys 76 2010 775 781
6. H.H. Liu, P. Balter, and T. Tutt Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer Int J Radiat Oncol Biol Phys 68 2007 531 540
7. National Cancer Institute Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, version 3.0. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3. pdf. Accessed May 1, 2009.
8. RTOG Toxicity-SOMA scales. Available at: http://www.rtog.org/members/ toxicity/soma.html. Accessed May 1, 2009.
9. W. Curran, R. Paulus, and C. Langer Sequential vs concurrent chemo radiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 2011 Sept 8 (ePub ahead of print)
10. P. Zatloukal, L. Petruzelka, and M. Zemanova Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study Lung Cancer 46 2004 87 98
11. P. Fournel, G. Robinet, and P. Thomas Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study J Clin Oncol 23 2005 5910 5917
12. J. Bradley A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group Semin Oncol 32 2005 S111 S113
13. S. Wang, Z. Liao, and X. Wei Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT) Int J Radiat Oncol Biol Phys 66 2006 1399 1407
14. B.R. Bastos, G.F. Hatoum, and G.R. Walker Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer J Thorac Oncol 5 2010 533 539
15. H. Murshed, H.H. Liu, and Z. Liao Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 2004 1258 1267
16. X. Wei, H.H. Liu, and S.L. Tucker Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 100 107